07-30-2006, 04:07 PM
Dear Ilja, Sophist and Violet,
By coincidence many of the studies that I have done have been collaboration with friends from different countries including The Netherlands (Utrecht and Maastricht). I was a presenter in this year’s 4th International Symposium on Autism celebrated in Rotterdam. I love the country and its people. See http://www.springerlink.com/media/3pvxun...755248.pdf
The proposed study has a time frame of 4 years. Not knowing the size effect of the treatment on outcome measures the time frame was selected as an approximate end. In this regard we need to collect a sufficient number of patients to show significance to the FDA and peer investigators. We may also have problems in training participants to receive therapy (basically staying still). In this regard we are limiting participation to high functioning autistic patients, at least initially. Without doing the study there are many unknowns including the duration of the trial and how long lasting are the effects.
In depression patients receiving TMS do so at longer and longer intervals. It seems quite possible that in the long run they can maintain the effect based on the plasticity of the minicolumn. Interestingly we did a study on a large series of pre and postnatal patients showing the development and maturation of the minicolumn (A Temporal Continuity of the Vertical Organization of the Human Neocortex, Cerebral Cortex, 2006). This structure is markedly plastic and responsive to environmental influences. Environmental influences having its greatest impact between 2 and 4 years of age. I have another article to appear in the next few months in The Neuroscientist that dwells more into the factors affecting the development of the minicolumn (a multifactorial trait with both genetic and environmental influences).
Why do I dwell on the cortex? The same has what are called phase transitions in its properties, e.g. like when water turns into ice. This means that there is evidence of self-organization in cortical arrangements that explains emergence of properties, that is, properties that can’t be explained in lieu of it individual components. In terms of a car it is the totality of the car that accounts for locomotion and a satisfying ride, e.g. transmission, axels, tires, radio, etc. In terms of the cortex by connecting different modules (minicolumns) together we obtain language, intellect, memory, orientation, etc. These are the properties that I am interested the most and that appear affected primarily in psychiatric conditions.
Incidentally the cortex is the most highly evolved area of the brain and accounts (along with its projections) for 70% of its volume. The addition of more and more minicolumns account for changes in how the brain is wired together, for cerebral dominance, and for specific functions such as language. Many of the observed changes are present only in humans and may be considered speciation events, i.e., changes in the brain that account for the unique abilities of homo sapiens.
TMS itself is quite safe. At low frequencies it has inhibitory effects. We believe it is due to selective strengthening of fibers at the periphery of the cell minicolumn. At higher and higher frequencies, the effects become less specific and all cells are stimulated. Since the majority of cells within the cortex are excitatory the end result in a susceptible individual may be a seizure. This is a very rare side effect of the therapy. In this regard we have proposed using very low frequencies in our study (less than 1 Hz).
The technique (TMS) does not need to be applied to the whole brain. We have found that there is a pattern of minicolumnar alterations within the brains of autistic patients (Clinical Neuroscience Res, also to appear published within the next few months). Areas that have the longest and most numerous connections appear affected the most. Otherwise areas that excel in intrinsic connectivity (e.g., visual cortex) are not affected; they may even work better than normal. This may explain why functions that need inter-areal integration (e.g., language, face recognition, joint attention) appear affected while others that emphasize intra-areal connectivity are spared or improved (e.g., visual discrimination, mathematical abilities).
Again, the technique is not meant to change how different cortical areas are wired nor the unique and charismatic way of thinking of a particular individual. It is only meant to build the inhibition around minicolumns so that information is not amplified and floods the cortex.
Thank you for allowing me to participate in your forum. Hopefully my discussion has not been too technical. Let me know if you have any additional questions.
Best regards,
Manuel
By coincidence many of the studies that I have done have been collaboration with friends from different countries including The Netherlands (Utrecht and Maastricht). I was a presenter in this year’s 4th International Symposium on Autism celebrated in Rotterdam. I love the country and its people. See http://www.springerlink.com/media/3pvxun...755248.pdf
The proposed study has a time frame of 4 years. Not knowing the size effect of the treatment on outcome measures the time frame was selected as an approximate end. In this regard we need to collect a sufficient number of patients to show significance to the FDA and peer investigators. We may also have problems in training participants to receive therapy (basically staying still). In this regard we are limiting participation to high functioning autistic patients, at least initially. Without doing the study there are many unknowns including the duration of the trial and how long lasting are the effects.
In depression patients receiving TMS do so at longer and longer intervals. It seems quite possible that in the long run they can maintain the effect based on the plasticity of the minicolumn. Interestingly we did a study on a large series of pre and postnatal patients showing the development and maturation of the minicolumn (A Temporal Continuity of the Vertical Organization of the Human Neocortex, Cerebral Cortex, 2006). This structure is markedly plastic and responsive to environmental influences. Environmental influences having its greatest impact between 2 and 4 years of age. I have another article to appear in the next few months in The Neuroscientist that dwells more into the factors affecting the development of the minicolumn (a multifactorial trait with both genetic and environmental influences).
Why do I dwell on the cortex? The same has what are called phase transitions in its properties, e.g. like when water turns into ice. This means that there is evidence of self-organization in cortical arrangements that explains emergence of properties, that is, properties that can’t be explained in lieu of it individual components. In terms of a car it is the totality of the car that accounts for locomotion and a satisfying ride, e.g. transmission, axels, tires, radio, etc. In terms of the cortex by connecting different modules (minicolumns) together we obtain language, intellect, memory, orientation, etc. These are the properties that I am interested the most and that appear affected primarily in psychiatric conditions.
Incidentally the cortex is the most highly evolved area of the brain and accounts (along with its projections) for 70% of its volume. The addition of more and more minicolumns account for changes in how the brain is wired together, for cerebral dominance, and for specific functions such as language. Many of the observed changes are present only in humans and may be considered speciation events, i.e., changes in the brain that account for the unique abilities of homo sapiens.
TMS itself is quite safe. At low frequencies it has inhibitory effects. We believe it is due to selective strengthening of fibers at the periphery of the cell minicolumn. At higher and higher frequencies, the effects become less specific and all cells are stimulated. Since the majority of cells within the cortex are excitatory the end result in a susceptible individual may be a seizure. This is a very rare side effect of the therapy. In this regard we have proposed using very low frequencies in our study (less than 1 Hz).
The technique (TMS) does not need to be applied to the whole brain. We have found that there is a pattern of minicolumnar alterations within the brains of autistic patients (Clinical Neuroscience Res, also to appear published within the next few months). Areas that have the longest and most numerous connections appear affected the most. Otherwise areas that excel in intrinsic connectivity (e.g., visual cortex) are not affected; they may even work better than normal. This may explain why functions that need inter-areal integration (e.g., language, face recognition, joint attention) appear affected while others that emphasize intra-areal connectivity are spared or improved (e.g., visual discrimination, mathematical abilities).
Again, the technique is not meant to change how different cortical areas are wired nor the unique and charismatic way of thinking of a particular individual. It is only meant to build the inhibition around minicolumns so that information is not amplified and floods the cortex.
Thank you for allowing me to participate in your forum. Hopefully my discussion has not been too technical. Let me know if you have any additional questions.
Best regards,
Manuel
